The New York and Presbyterian Hospital

Not-for-profit hospital

Based in NY

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $1.8M in lobbying spend across 39 quarterly filings, The New York and Presbyterian Hospital is a significant lobbying presence. They deploy 31 individual lobbyists Their lobbying covers 4 issue areas. Active from 2018 to 2025.

$1.8M
Total Spend
8
Years Active
1
Firms Hired
31
Lobbyists Deployed
4
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$160K
2019$240K
2020$320K
2021$250K
2022$200K
2023$200K
2024$200K
2025$200K

Issues Lobbied

Health IssuesMedicare/MedicaidBudget/AppropriationsTaxation

Lobbying Firms

Mehlman Consulting, INC.

Lobbyists

Bruce MehlmanDavid CastagnettiDean RosenDavid ThomasElise Finley PickeringCharles WootersSohini GuptaSage EastmanLauren AronsonMichael RobinsonMichael CollinsConstantine HingsonSteve HaroHelen TolarNichole DistefanoMckenzie BricePaul ThornellStephen CoteAlexander PerkinsVictoria FloodRosemary GutierrezZachary MalloveCaitlin Van SantLisa GoldmanAlyene MlinarErica ChabotAnnie WolfNaveen ParmarJon AdameJoseph BrownEarl Flood

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid, Budget/Appropriations, Taxation

Graham-Cassidy Amendment; The Bi-partisan Healthcare Stabilization Act of 2017 (Alexander-Murray).

S. 870 - Creating High-Quality Results and Outcomes Necessary to Improve Chronic Care Act (CHRONIC Act).

S. 1016 - Creating Opportunities Now for Necessary and Effective Care Technologies for Health Act (CONNECT Act).

340B Drug Pricing Program.

Cyber-security related to Healthcare data.

H.R. 1625 - Consolidated Appropriations Act of 2018.

H.R. 1892 - Balanced Budget Act of 2018.

Graham-Cassidy Amendment; The Bi-partisan Healthcare Stabilization Act of 2017 (Alexander-Murray).

S. 870 - Creating High-Quality Results and Outcomes Necessary to Improve Chronic Care Act (CHRONIC Act).

Medicaid issues.

340B Drug Pricing Program.

H.R. 1625 - Consolidated Appropriations Act of 2018.

H.R. 1892 - Balanced Budget Act of 2018.

Medicaid issues.

340B Drug Pricing Program.

Medicare hospital reimbursement.

S. 1016 - Creating Opportunities Now for Necessary and Effective Care Technologies for Health Act (CONNECT Act).

340B Drug Pricing Program.

Cyber-security related to Healthcare data.

340B Drug Pricing Program.

Liver allocation issues.

Site Neutrality.

Site Neutrality.

Graduate Medical Education Funding.

S.1895 - Lower Health Care Costs Act

H.R.3417 - Beneficiary Education Tools, Telehealth, and Extenders Reauthorization Act of 2019

Site Neutrality.

Graduate Medical Education Funding.

H.R.3417 - Beneficiary Education Tools, Telehealth, and Extenders Reauthorization Act of 2019

Showing 8 of 20 unique descriptions from filings.

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?
🏭 Pharma Lobbying
Industry overview and top spenders

Related Investigations

Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
The 22,000% ROI
When lobbying spending yields outsized returns.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.